IHP 310 Pathophysiology and Pharmacology Concepts sample papers, module by module

Reviewed by Delia Ravenscroft, MSN, RN Pathophysiology and Pharmacology Concepts Southern New Hampshire University Free custom samples in 24–48h

IHP 310 asks you to explain what goes wrong in a body system and what a drug class does about it, in writing an administrator can act on. Our samples show that pairing worked end to end.

How this shelf works

Send the exact assignment or rubric from your classroom and a custom sample written to it lands in 24 to 48 hours, the first one free. IHP 310 is SNHU’s Pathophysiology and Pharmacology Concepts course. It centers on how disease processes alter normal function and how drug classes act on them, read for administrators rather than prescribers. Searches like "ihp 310 module 4 assignment example", "IHP310 sample paper", and "IHP 310 module samples" land on this page.

What IHP 310 is really about

IHP 310 sits early in the health professions sequence, and it is written for people who will manage services rather than prescribe. Modules typically open with cell injury, inflammation and the general mechanisms of disease, then move through cardiovascular, respiratory, endocrine, neurological and immune material. Pharmacology runs alongside rather than after. As each system arrives, so do the drug classes used against it, with attention to mechanism of action, common adverse effects and what has to be monitored. The writing that comes out of it is explanatory. You say what is happening in the tissue, what the agent does to that process, and why the pairing matters to a reader who is not a clinician.

Deliverables in many sections follow a steady beat. A discussion opens most modules and a written assignment lands in the second slot, which is why students search strings like 3-2 Assignment or 5-2 Assignment when they go looking for a model. A larger case analysis commonly sits in the back half of the term, assembled from smaller stepping stone pieces handed in earlier. The rubric usually rewards two things at once, accuracy about the mechanism and clarity for a reader without clinical training. That pairing is where points quietly leak, because a paper can be right about the biology and still leave a manager with nothing to do.

What IHP 310’s assessments ask for

Expect scenarios rather than quizzes. A short case gives you a person with a diagnosis, a set of signs and a medication list, and the paper has to explain the disease process in order, from initiating insult to the symptoms the case describes. Then the pharmacology half: which class was chosen, what it does at the receptor or enzyme level, why it fits this presentation, and what the care team watches for while it is running. Later modules usually raise the stakes by adding a second condition or an interaction, so the explanation has to hold two processes at once. Citations are expected, and drug information belongs to pharmacology references rather than to a general search result.

Where students lose points in IHP 310

Points go missing in one predictable place. A paper opens by calling a condition common, or an adverse effect frequent, and stops there. Common in whom, out of how many, across what period? A figure with no population underneath it and no interval attached is an assertion, not evidence, and a grader checking against the rubric has nothing to verify. The same gap shows up in the monitoring paragraph, where a side effect is called routine with no exposed group and no observation window behind the word. The repair is mechanical. Write every quantity as a share of a stated population over a stated span, then name the source that produced it.

IHP 310 grading scale at SNHU: how the work is graded, from SNHU Assignments
How SNHU grades IHP 310, visualized by SNHU Assignments.

The IHP 310 drawers

Module 1

IHP 310 Module 1 Cell Injury Discussion example

An opening discussion post: carbon monoxide poisoning used to explain hypoxic cell injury, reversible versus irreversible damage, and oxygen as a drug. Full sample paper, annotated.

Read the sample →
Module 2

IHP 310 Module 2 Cardiovascular and Hematopoietic Case Study example

A cardiovascular and hematopoietic drug treatment case study: swollen ankles from amlodipine and a B12 anemia from eight years of metformin. Full sample paper, annotated.

Read the sample →
Module 3

IHP 310 Module 3 Respiratory Drug Treatment Analysis example

A respiratory mechanism and drug analysis: asthma that worsened after timolol eye drops, traced from beta receptors to a safer glaucoma choice. Full sample paper, annotated.

Read the sample →
Module 4

IHP 310 Module 4 Endocrine and Neural Case Study example

An endocrine and neural drug treatment case study: a man stable on lithium for bipolar disorder whose new tiredness is hypothyroidism, not relapse. Full sample paper, annotated.

Read the sample →
Module 5

IHP 310 Module 5 Patient Chart Review Milestone example

A patient chart review milestone: Parkinson disease worsening after a nausea drug that blocks dopamine, found by reading the record line by line. Full sample paper, annotated.

Read the sample →
Module 6

IHP 310 Module 6 Infection and Antimicrobial Case Analysis example

An infection and antimicrobial case analysis: cloudy urine, a positive culture, a week of ciprofloxacin and the C. difficile infection that followed. Full sample paper, annotated.

Read the sample →
Module 7

IHP 310 Module 7 Comorbidity Discussion example

A comorbidity discussion post: heart failure, diabetes and knee arthritis, where pioglitazone and ibuprofen each push the same failing heart toward fluid overload. Full sample paper, annotated.

Read the sample →
Module 8

IHP 310 Module 8 Final Case Analysis example

A final case analysis: an antibiotic for cellulitis tips a heart failure patient on three potassium-raising drugs into dangerous hyperkalemia. Full sample paper, annotated.

Read the sample →
Different?

Your classroom shows something else?

Southern New Hampshire University revises courses; module counts and deliverables shift between terms. Send what your classroom shows and the desk matches it exactly.

Send it over →

Using a IHP 310 sample the right way

Read the sample for structure before you borrow anything from it. Notice where the mechanism paragraph ends and the drug rationale begins, how the two are stitched with a sentence that names the target, and how each quantity carries its population and its period. Then rebuild those moves on your own case, in your own words, with your own sources. Send us the instructions and the rubric for your section and the first custom sample is free, back in 24-48h, written against your prompt rather than a generic version of it.

How these samples are written

The discipline behind every paper here: the rubric is the outline, each row gets its section, milestone sequences stay coherent so the final submission reads as one build, and the format layer ships exact. Send your dash-code and rubric with a request and the sample matches them, revisions included.

IHP 310 questions, answered

How do I say a condition is common without overstating it?

Give the number a home. Report prevalence or incidence as a share of a named population across a stated period, cite the surveillance source that published it, and say plainly whether the figure is national or local. One sentence of that kind does more for the rubric than a paragraph of adjectives, and it survives a grader who checks.

The rubric wants adverse effects discussed. Is naming them enough?

Rarely. A list of effects with no rate behind it reads as memorization. Say how often the effect appears, in what exposed group, over what length of therapy, and what monitoring follows from that frequency. The pharmacology reference you cite will usually carry those numbers, and pulling them across is what turns a list into analysis.

Can I see how a paper handles those numbers before I commit?

Yes. Send the instructions and rubric for the module you are on and we write the first custom sample free, back inside 24-48h. Most students use it on an early module assignment, then reuse the shape of the evidence sentences for the rest of the term without asking again.